Clinical Trials Browser

INDUSTRY × Interventional × Ultracet × Clear all

NCT01968018 2013-10-23

A Study of Safety and Effectiveness of Ultracet in Patients With Chronic Cancer Pain

Phase 4 Completed

Neoplasms

NCT00576173 2010-04-28

An Open Label Study to Evaluate Safety, Tolerability and Clinical Utility of ULTRACET® (37.5mg Tramadol Hydrochloride/325mg Acetaminophen) for the Treatment of Breakthrough Pain in Cancer Patients

Phase 4 Completed

Cancer Pain, Pain, Breakthrough Pain